LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Enzo Biochem Inc

Fechado

SetorSaúde

0.31 -13.89

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.3

Máximo

0.36

Indicadores-chave

By Trading Economics

Rendimento

1.8M

-1.5M

Vendas

1.1M

7.3M

EPS

-0.029

Rendimento de Dividendos

125

Margem de lucro

-20.93

Funcionários

125

EBITDA

1.6M

-1.3M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

125.00%

2.45%

Próximos Ganhos

11 de jun. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-7.8M

16M

Abertura anterior

14.2

Fecho anterior

0.31

Sentimento de Notícias

By Acuity

24%

76%

56 / 382 Ranking em Healthcare

Enzo Biochem Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de mai. de 2025, 19:39 UTC

Grandes Movimentos do Mercado

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

16 de mai. de 2025, 23:18 UTC

Principais Notícias

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16 de mai. de 2025, 22:30 UTC

Principais Notícias

U.S. Loses Last Triple-A Credit Rating -- Update

16 de mai. de 2025, 21:56 UTC

Conversa de Mercado

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16 de mai. de 2025, 21:56 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

16 de mai. de 2025, 21:54 UTC

Principais Notícias

U.S. Loses Last Triple-A Credit Rating -- WSJ

16 de mai. de 2025, 21:22 UTC

Conversa de Mercado

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16 de mai. de 2025, 21:17 UTC

Conversa de Mercado

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16 de mai. de 2025, 21:17 UTC

Principais Notícias

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16 de mai. de 2025, 21:05 UTC

Conversa de Mercado

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16 de mai. de 2025, 20:55 UTC

Aquisições, Fusões, Aquisições de Empresas

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 de mai. de 2025, 20:50 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

16 de mai. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

16 de mai. de 2025, 20:37 UTC

Principais Notícias

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16 de mai. de 2025, 20:33 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16 de mai. de 2025, 20:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16 de mai. de 2025, 20:18 UTC

Principais Notícias

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16 de mai. de 2025, 20:16 UTC

Principais Notícias

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16 de mai. de 2025, 20:15 UTC

Ganhos

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16 de mai. de 2025, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Henry Schein: William K. Daniel Joins Board

16 de mai. de 2025, 20:10 UTC

Aquisições, Fusões, Aquisições de Empresas

Henry Schein: Strategic Investment by KKR Completed

16 de mai. de 2025, 20:05 UTC

Aquisições, Fusões, Aquisições de Empresas

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 de mai. de 2025, 19:38 UTC

Conversa de Mercado

Oil Futures Post Second Straight Weekly Gain -- Market Talk

16 de mai. de 2025, 19:07 UTC

Conversa de Mercado

U.S. Natural Gas Futures End Week Lower -- Market Talk

16 de mai. de 2025, 18:51 UTC

Principais Notícias

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

16 de mai. de 2025, 18:41 UTC

Aquisições, Fusões, Aquisições de Empresas

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 de mai. de 2025, 18:37 UTC

Conversa de Mercado

Gold Futures End Week on Negative Note -- Market Talk

16 de mai. de 2025, 18:35 UTC

Principais Notícias

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 3rd Update

16 de mai. de 2025, 18:32 UTC

Principais Notícias

Trump Floats Plan to Impose New Tariff Rates; Stocks Hold Steady -- WSJ

16 de mai. de 2025, 18:28 UTC

Conversa de Mercado

Weaker Dollar Seen as Helping Some Business to Avoid Price Increases -- Market Talk

Comparação entre Pares

Variação de preço

Enzo Biochem Inc Previsão

Sentimento

By Acuity

56 / 382 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Enzo Biochem Inc

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.